Gene · 900
Papers2,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. | Urol Oncol | 2022 | 35618577 | PubTator, text mining | PubMed |
| Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial. | Sci Rep | 2022 | 35595817 | PubTator, text mining | PubMed |
| Liquid Biopsy in Squamous Cell Carcinoma of the Esophagus and of the Head and Neck. | Front Med (Lausanne) | 2022 | 35572996 | PubTator, text mining | PubMed |
| Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma. | Clin Cancer Res | 2022 | 35552677 | PubTator, text mining | PubMed |
| Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management. | Nat Rev Clin Oncol | 2022 | 35534623 | PubTator, text mining | PubMed |
| The role of NSD1, NSD2, and NSD3 histone methyltransferases in solid tumors. | Cell Mol Life Sci | 2022 | 35532818 | PubTator, text mining | PubMed |
| Lineage Differentiation Potential of Different Sources of Mesenchymal Stem Cells for Osteoarthritis Knee. | Pharmaceuticals (Basel) | 2022 | 35455383 | PubTator, text mining | PubMed |
| Noncoding RNAs in the Glycolysis of Ovarian Cancer. | Front Pharmacol | 2022 | 35431949 | PubTator, text mining | PubMed |
| Do Safe Bike Lanes Really Slow Down Cars? A Simulation-Based Approach to Investigate the Effect of Retrofitting Safe Cycling Lanes on Vehicular Traffic. | Int J Environ Res Public Health | 2022 | 35409499 | PubTator, text mining | PubMed |
| Transcription Profile and Pathway Analysis of the Endocannabinoid Receptor Inverse Agonist AM630 in the Core and Infiltrative Boundary of Human Glioblastoma Cells. | Molecules | 2022 | 35408449 | PubTator, text mining | PubMed |
| Exosome-Mediated Therapeutic Strategies for Management of Solid and Hematological Malignancies. | Cells | 2022 | 35406692 | PubTator, text mining | PubMed |
| METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma. | J Cancer | 2022 | 35399719 | PubTator, text mining | PubMed |
| SARS-CoV-2 antigen exposure history shapes phenotypes and specificity of memory CD8+ T cells. | Nat Immunol | 2022 | 35383307 | PubTator, text mining | PubMed |
| Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes. | BMJ Open Sport Exerc Med | 2022 | 35368514 | PubTator, text mining | PubMed |
| Roles of lncRNAs Mediating Wnt/β-Catenin Signaling in HCC. | Front Oncol | 2022 | 35356220 | PubTator, text mining | PubMed |
| Comparing optimization criteria in antibiotic allocation protocols. | R Soc Open Sci | 2022 | 35345436 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Differential Gene and MicroRNA Expression in Lung Adenocarcinoma: Genetic Effects on Patient Prognosis, as Indicated by the TCGA Database. | Cancer Inform | 2022 | 35342284 | PubTator, text mining | PubMed |
| MicroRNA as a Potential Therapeutic Molecule in Cancer. | Cells | 2022 | 35326459 | PubTator, text mining | PubMed |
| Aerobic exercise elicits clinical adaptations in myotonic dystrophy type 1 patients independently of pathophysiological changes. | J Clin Invest | 2022 | 35316212 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/900/papers?page=17